Stockscreener 앱 받기
23.06
5.49%
1.20
시간 외 거래:
24.05
0.99
+4.29%
전일 마감가:
$21.86
열려 있는:
$22
하루 거래량:
90,971
Relative Volume:
1.29
시가총액:
$769.83M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+5.49%
1개월 성능:
-2.91%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$20.98
$23.88
1주일 범위
$20.98
$23.88
52주 변동 폭
$19.33
$26.19
Mbx Biosciences Inc Stock (MBX) Company Profile
Mbx Biosciences Inc 주식(MBX)의 최신 뉴스
MBX Biosciences (NYSE:MBX) Shares Up 8.2%Time to Buy? - MarketBeat
MBX Biosciences (NYSE:MBX) Shares Gap DownTime to Sell? - MarketBeat
MBX Biosciences (NYSE:MBX) Shares Up 6.8%Should You Buy? - MarketBeat
MBX Biosciences (NYSE:MBX) Sets New 52-Week LowTime to Sell? - MarketBeat
MBX Biosciences to Participate in Upcoming November Investor Conferences - GlobeNewswire
MBX Biosciences (NYSE:MBX) Shares Down 4.5%Here's What Happened - MarketBeat
MBX Biosciences sets IPO terms with plans to raise up to $136 million - MSN
MBX Biosciences, Inc.'s Quiet Period Set To Expire on October 23rd (NYSE:MBX) - MarketBeat
MBX Biosciences, Inc.’s Quiet Period Set To Expire on October 23rd (NYSE:MBX) - Defense World
MBX Biosciences (NYSE:MBX) Stock Price Down 4%Here's Why - MarketBeat
MBX Bio drops despite bullish views on Street - MSN
MBX Biosciences (NYSE:MBX) Shares Up 4.6%Here's What Happened - MarketBeat
MBX Biosciences earns Buy rating at three investment firms - MSN
MBX Bio stock drops despite bullish initiations (NASDAQ:MBX) - Seeking Alpha
MBX Biosciences (NYSE:MBX) Shares Gap UpHere's Why - MarketBeat
Guggenheim bullish on MBX Biosciences stock, driven by MBX 2109 potential - Investing.com Canada
MBX Biosciences outlook solid with JPMorgan's overweight rating, eyes key catalysts in next 12 months - Investing.com India
Jefferies sees upside in MBX Biosciences stock, highlights PEP platform advancements - Investing.com India
MBX Biosciences earns Buy rating at three investment firms By Investing.com - Investing.com Canada
Guggenheim Begins Coverage on MBX Biosciences (NYSE:MBX) - Defense World
MBX Biosciences (NYSE:MBX) Now Covered by JPMorgan Chase & Co. - MarketBeat
Jefferies sees upside in MBX Biosciences stock, highlights PEP platform advancements By Investing.com - Investing.com South Africa
MBX Biosciences (NYSE:MBX) Stock Price Down 3.5%Should You Sell? - MarketBeat
MBX Biosciences Presents MBX 2109 Phase 2 Avail™ - GlobeNewswire
MBX Biosciences Presents MBX 2109 Phase 2 Avail™ Hypoparathyroidism Trial Rationale and Design at the ASBMR 2024 Annual Meeting - Yahoo Finance
MBX Biosciences (NYSE:MBX) Trading Down 4.1% - MarketBeat
MacroGenics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationMGNX - PR Newswire
HighVista Strategies LLC Lowers Stock Holdings in MoonLake Immunotherapeutics (NASDAQ:MLTX) - Defense World
Shareholders that lost money on MacroGenics, Inc.(MGNX) Urged to Join Class ActionContact The Gross Law Firm to Learn More - Lelezard
330 Shares in Monolithic Power Systems, Inc. (NASDAQ:MPWR) Bought by Brighton Jones LLC - Defense World
Westwood Holdings Group Inc. Grows Holdings in Mplx Lp (NYSE:MPLX) - Defense World
Hagens Berman Reminds MacroGenics (MGNX) Investors of the Pending Class Action Lawsuit with a Lead Plaintiff - EIN News
MGNX Deadline: MGNX Investors Have Opportunity to Lead MacroGenics, Inc. Securities Fraud Lawsuit - Lelezard
Bridges Investment Management Inc. Invests $2.87 Million in Mplx Lp (NYSE:MPLX) - Defense World
Mplx Lp (NYSE:MPLX) Shares Acquired by Parallel Advisors LLC - Defense World
Upstream Bio goes public amid spate of IPOs - The Pharma Letter
Life Sciences X. L.P. Frazier Acquires 625,000 Shares of MBX Biosciences, Inc. (NYSE:MBX) Stock - Defense World
Edward T. Mathers Purchases 500,000 Shares of MBX Biosciences, Inc. (NYSE:MBX) Stock - Defense World
Tuesday's Insider Trades: Major Buys at MBX Biosciences, Sells at Palantir By Investing.com - Investing.com South Africa
Tuesday's Insider Trades: Major Buys at MBX Biosciences, Sells at Palantir - Investing.com India
Private Advisor Group LLC Has $660,000 Stock Holdings in Monolithic Power Systems, Inc. (NASDAQ:MPWR) - Defense World
Barclays Lowers Mplx (NYSE:MPLX) Price Target to $45.00 - Defense World
WINTON GROUP Ltd Makes New $633,000 Investment in Monolithic Power Systems, Inc. (NASDAQ:MPWR) - MarketBeat
MBX Biosciences insider purchases $8 million in company stock By Investing.com - Investing.com South Africa
MBX Biosciences insider buys $8 million in company stock By Investing.com - Investing.com South Africa
MBX Biosciences insiders purchase $10 million in stock By Investing.com - Investing.com South Africa
MBX Biosciences director buys $8 million in company stock - Investing.com India
MBX Biosciences director buys $8 million in company stock By Investing.com - Investing.com Australia
MBX Biosciences insider purchases $8 million in company stock - Investing.com
MBX Biosciences insider buys $8 million in company stock - Investing.com
Mbx Biosciences Inc (MBX) 재무 분석
Mbx Biosciences Inc (MBX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
2.02%
0.47%
자본화:
|
볼륨(24시간):